by EmpathiCSubstanceS | Apr 29, 2021 | MDMA Sassafras Molly
The last decade has been inarguably incredible for the field of psychedelic science. The term renaissance is hyperbolically thrown around a lot these days but in this context it is perfectly apt. Moving from the fringes of the research world and shaking off years of...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, CBC, MDMA Sassafras Molly
A new study, led by researchers from University College London, is offering some of the first robust evidence showing how cannabidiol (CBD), a key compound in cannabis, increases cerebral blood flow in memory processing regions of the brain such as the hippocampus....
by EmpathiCSubstanceS | Apr 25, 2021 | MDMA Sassafras Molly
Psychedelic pharmaceutical company MindMed is set to conduct a novel Phase 1 clinical trial exploring the subjective effects of combining LSD with MDMA. The primary goal of the prospective study is to investigate whether MDMA, a drug known to induce feelings of...
by EmpathiCSubstanceS | Apr 25, 2021 | MDMA Sassafras Molly
In the late 1970s and early 1980s MDMA was often utilized to help facilitate positive results in couples counseling. A few dozen pioneering psychotherapists in the United States explored the drug’s therapeutic uses until the US government declared MDMA a Schedule 1...
by EmpathiCSubstanceS | Apr 25, 2021 | Cannabis Marijuana, MDMA Sassafras Molly
A team of Australian scientists has demonstrated a novel microencapsulation method designed to improve the absorption and bioavailability of cannabidiol (CBD). Animal tests suggest the new method increases peak concentrations of CBD in the brain by 300 percent...
by EmpathiCSubstanceS | Nov 4, 2020 | MDMA Sassafras Molly
MDMA, the man-made drug often called ecstasy or molly, has a colorful history. It was patented in 1914 by the German drug company Merck, and set aside for decades. The US Army studied it during the Cold War, perhaps seeking a chemical weapon or interrogation tool....
